Portefaix, A
Rabilloud, M
Baudin, F
Dantony, E
Ginhoux, T
Kassaï-Koupaï, B
Javouhey, E
Bordet, F
Funding for this research was provided by:
Fondation de France
APICIL
ALLP, Adène Groupe
Hospices Civils de Lyon
Article History
Received: 9 April 2026
Revised: 9 April 2026
Accepted: 23 April 2026
First Online: 2 May 2026
Declarations
:
: Clinical Trial number: (NCT02847195). The trial was approved by the French Southeast IV Ethics Committee (2014–026-2) in November 2014, the French National Agency for Medicines and Health Products Safety (ANSM ID RCB: 2013-A01600-45) in November 2013, and French data protection authority (CNIL declaration #1814110) in December 2014.
: The authors declare no competing interests.